Correlation of serum and salivary CA15-3 levels in patients with breast cancer [PDF]
Medicina Oral Patología Oral y Cirugia Bucal, 2009 Objectives: The aim of this study was to assess the relationship between serum and saliva levels of cancer antigen (CA) 15-3 and to compare them between women with and without breast cancer.
Agha-Hosseini, Farzaneh +2 more
core +4 more sources
Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level. [PDF]
J Breast Cancer, 2023 Cancer antigen 15-3 (CA15-3) is a serum tumor marker for breast cancer (BC) extensively used in clinical practice. CA15-3 is non-invasive, easily available, and a cost-effective tumor marker for immediate diagnosis, monitoring and prediction of BC recurrence.
Ryu JM +14 more
europepmc +3 more sources
Relationship between tumor markers CEA and CA15-3 and recurrence breast cancer [PDF]
Archives of Advances in Biosciences, 2012 The value of clinical use of tumor markers CEA and CA15-3 for early detection of recurrent breast cancer still is a controversial. This study was investigated relationship between tumor markers CEA and CA15-3 and recurrence breast cancer.
Keyhanian, Shahrbano, Rad Ghasabeh, Hadi
core +3 more sources
Use of CA15‑3 for screening breast cancer: An antibody‑lectin sandwich assay for detecting glycosylation of CA15‑3 in sera. [PDF]
Oncol Rep, 2018 Elevated serum CA15‑3 assessed by enzyme‑linked immunosorbent assay (ELISA) has been considered a diagnostic marker of breast cancer. However, accumulating data indicate that the current ELISA system for detecting CA15‑3, which targets the peptide backbone of CA15‑3, is not sufficiently sensitive to detect early or localized breast cancer.
Choi JW +5 more
europepmc +4 more sources
Correlation between salivary and serum CA15-3 concentrations in patients with breast cancer. [PDF]
Mol Clin Oncol, 2020 The early detection of breast cancer enables the use of less aggressive treatment and increases patient survival. The transmembrane glycoprotein mucin 1, which is also known as cancer antigen 15-3 (CA15-3), is aberrantly glycosylated and overexpressed in a variety of epithelial cancers, and serves a crucial role in the progression of the disease.
Assad DX +8 more
europepmc +4 more sources
Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients. [PDF]
PLoS ONE, 2016 Previous studies have indicated that carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) levels are both independent prognostic factors in breast cancer.
Danian Dai +6 more
doaj +1 more source
Elevated CA15-3 Levels in Myeloid Disorders: Clinicopathological Correlation
European Journal of Cancer Care, 2022 Abstract The authors have requested that this preprint be removed from Research Square.
Samah Saharti, Mohamad Qari
openaire +1 more source
Annals of Medicine, 2023 Objective The exploration of non-invasive biomarkers for assessing tumor response is critical to optimize treatment decisions. In this study, we aimed at determining the potential role of RAI14 in the early diagnosis and evaluation of chemotherapy ...
Ranliang Cui +5 more
doaj +1 more source
Improved breast cancer diagnosis using a CA15-3 capture antibody-lectin sandwich assay. [PDF]
Breast Cancer Res TreatAbstract Purpose This study aims to test the hypothesis that an enzyme-linked antibody-lectin sandwich assay for a glycovariant of CA15-3 can deliver better diagnostic performance, defined by classification accuracy, sensitivity and specificity, for breast cancer compared to an existing FDA-approved CA15-3 test.
Nikseresht S +12 more
europepmc +3 more sources
Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies [PDF]
, 2009 Aim: PankoMab is a novel antibody that recognizes a tumor-specific epitope of Mucin 1 (MUC1). The aim of this study was the evaluation of PankoMab as a potential diagnostic tool and its comparison with two established antibodies against MUC1 in human ...
Dian, Darius +7 more
core +1 more source